Medtronic transcatheter therapies excellent outcomes in congenital heart disease, aortic stenosis

 Medtronic, the global leader in healthcare technology, today announced the release of important clinical outcomes in two leading transcatheter valve therapies. The results for these studies were presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions in Long Beach, CA. [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.

Attachments

• Original Link
• Permalink

https://www.marketscreener.com/quote/stock/MEDTRONIC-PLC-20661655/news/SCAI-2024-Medtronic-transcatheter-therapies-show-excellent-outcomes-in-the-treatment-of-congenital-46631386/